Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
VK2735 for Weight Management Phase 3NCT07104500VKTXPhase 3Active not recruiting2027-07-01Estimated
A Study to Assess Anktiva in Patients With Long Covid-19.NCT07108036IBRXPhase 2Recruiting2026-10Estimated
Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to TrikaftaNCT07108153SIONPhase 2Completed2026-06-25Actual
Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar DisorderNCT07116694BioXcel Therapeutics IncPhase 2Completed2025-10-07Actual
A Study to Examine Anktiva for the Treatment of COVID-19.NCT07123727IBRXPhase 2Recruiting2027-03Estimated
Study of Relapsed/ Refractory B-cell Non- Hodgkin LymphomaNCT07125872IBRXPhase 2Recruiting2027-05-25Estimated
A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With BulevirtideNCT07128550VIRPhase 3Active not recruiting2026-12Estimated
SPN-817 Open-Label Extension Study in Adults With Focal Onset SeizuresNCT07141329SUPNPhase 2Enrolling by invitation2027-12-31Estimated
A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV InfectionNCT07142811VIRPhase 2Active not recruiting2029-03Estimated
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)NCT07146022MANEPhase 3Active not recruiting2027-06Estimated
A Study of SPY072 in Rheumatic DiseaseNCT07148414SYREPhase 2Active not recruiting2026-10-31Estimated
Phase 2b Study of EVO756 in Adults With Atopic DermatitisNCT07150845EVMNPhase 2Completed2026-07-23Actual
Challenge Transfusion of INTERCEPT Pathogen Reduced Red Blood Cells (RBCs) in Subjects With or Without Pre-existing Antibodies to INTERCEPT RBCsNCT07152379Cerus CorporationPhase 2Not yet recruiting2030-09-30Estimated
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)NCT07154706NUVBPhase 3Recruiting2030-08-30Estimated
A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)NCT07156578RYTMPhase 2Enrolling by invitation2028-04-15Estimated
Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19NCT07157007TRAWPhase 2Completed2026-02-16Actual
A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)NCT07157254RAREPhase 2Terminated2026-10-30Actual
Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AMLNCT07157514Actinium PharmaceuticalsPhase 2, Phase 3Not yet recruiting2029-02Estimated
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)NCT07160634SLDBPhase 3Recruiting2029-01Estimated
An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)NCT07161700Seaport TherapeuticsPhase 2Enrolling by invitation2027-05Estimated
Study of COYA 302 for the Treatment of ALSNCT07161999Coya TherapeuticsPhase 2, Phase 3Active not recruiting2027-04Estimated
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)NCT07172516XENEPhase 3Active not recruiting2028-06Estimated
An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry EyeNCT07179055Vanda PharmaceuticalsPhase 2Recruiting2026-09Estimated
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon MutationsNCT07185997AVBPPhase 3Recruiting2029-02Estimated
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 DiabetesNCT07187531SABSPhase 2Recruiting2027-11Estimated
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell TherapyNCT07188558LYELPhase 3Recruiting2029-12Estimated
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsNCT07189871RADXPhase 1, Phase 2Recruiting2027-12Estimated
AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPFNCT07194382AVLNPhase 2Recruiting2026-12Estimated
The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) TrialNCT07197034AARDPhase 3Terminated2026-04-15Actual
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain VirusNCT07198139COCPPhase 1, Phase 2Completed2026-09-14Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.